Quantification of 99tcm-sestamibi 123i-bmipp uptake for predicting functional outcome in chronically ischaemic dysfunctional myocardium

Nuclear Medicine Communications

Volumn 20, Issue 8, 1999, Pages 737-746

  Hambye, A S ^a   Vervaet, A ^a   Dobbeleir, A ^a  

^a MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; DOBUTAMINE; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; 15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123;

AGED; ARTICLE; CHRONIC DISEASE; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; SCINTISCANNING; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; ADULT; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DIAGNOSTIC VALUE; HEART SCINTISCANNING; INTERVENTIONAL RADIOLOGY; QUANTITATIVE DIAGNOSIS; STRESS ECHOCARDIOGRAPHY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHRONIC DISEASE; CORONARY ARTERY BYPASS; DOBUTAMINE; ECHOCARDIOGRAPHY; FATTY ACIDS; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032587289     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199908000-00008     Document Type: Article

References (22)

1. Knapp FF Jr, Ambrose KR, Goodman MM. New radio-iodinated methyl branched fatty acids for cardiac studies. Eur f Nucl Med 1986; 12: S39-S44.
2. Tateno M, Tamaki N, Yukihiro M et al. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 1996; 37: 1981-1985.
3. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: Correlation with wall motion and inotropic reserve. J Nucl Med 1994; 35: 1758-1765.
4. De Geeter F, Franken PR, Knaff FF, Bossuyt A. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: A study by means of “Tcm-sestamibi and 123I-P-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994; 21: 283-291.
5. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37: 718-722.
6. Sawada SG, Allman KC, Muzik O et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994; 23: 92-98.
7. McGillem MJ, DeBoe SF, Friedman HZ, Mancini GBJ. The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairments of reactive hyperemia. Am Heart J 1988; 115: 970-977.
8. Hambye AS, Vaerenberg M, Dobbeleir A, Van den Heuvel P, Franken PR. Abnormal BMIPP uptake in chronically dysfunctional myocardial segments: Correlation with con-tractile response to low-dose dobutamine. J Nucl Med 1998; 39: 1845-1850.
9. Hambye AS, Dobbeleir A, Franken PR. SPET generated colour-coded polar maps to quantify the uptake of “Tcm-sestaMIBI and 123I-BMIPP in chronically dysfunctional myocardium: Comparison with coronary anatomy and wall motion. Nucl Med Commun 1997; 18: 1135-1147.
10. Di Carli MF, Davidson N, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
11. Afridi I, Graynburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998; 32: 921-926.
12. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
13. Mertens J, Eersels J, Van Ryckeghem W. New high yield Cu(I) assisted 1-123 radioiodination of 15(p-iodo-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 1987; 13: 159-160.
14. Dobbeleir A, Hambye AS, Franken PR. Influence of the methodology on the presence and extent of mismatching between “Tcm-MIBI and 123I-BMIPP in myocardial viability studies. J Nucl Med 1999; 40: 707-714.
15. Chouraqui P, Maddahi J, Henkin R, Karesh SM, Galie E, Berman DS. Comparison of myocardial imaging with iodine-123-iodophenyl-9-methyl pentadecanoic acid and thallium-201-chloride for assessment of patients with exercise-induced myocardial ischemia. J Nucl Med 1991; 32: 447-452.
16. Kawamoto M, Tamaki N, Yonekura Y et al. Significance of myocardial uptake of iodine 123-I-labeled beta-methyl iodophenyl pentadecanoic acid: Comparison with kinetics of carbon 11-labeled palmitate in positron emission tomography. J Nucl Cardiol 1994; 1: 522-528.
17. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) Technetium (I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.
18. Altehoefer C, vom Dahl J, Biedermann Met al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: Comparison with fluorine-18-FDG PET. Eur J Nucl Med 1994; 35: 569-574.
19. Fujibayashi Y, Yonekura Y, Takemura Y et al. Myocardial accumulation of iodinated beta-methyl branched fatty acid analogue, iodine-125-15-(p-iodophenyI)-3-(R, S) methyl pentadecanoic acid (BMIPP) in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822.
20. Sloof GW, Visser FC, Bax JJ et al. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: Comparison with fluorine-18-FDG SPECT. J Nucl Med 1998; 39: 255-260.
21. Tamaki N, Tadamura E, Kudoh T et al. Prognostic value of iodine-123-labelled BMIPP fatty acid analogue in patients with myocardial infarction. Eur J Nucl Med 1996; 23: 272-279.
22. Taki J, Nakajima K, Matsunari I et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997; 38: 1503-1510.